Table 3.

Follow up of patients injected with M-FP

Patient number	Age (years)	Date of surgery	Type of treatment	Tumour size (cm)	Total nodes	Metastatic nodes	Grade	Date of first injection	Side effects	Recurrence	Last follow up	Follow up (months)
1	58	02/12/97	Partial mast + RT + tam	1.0	17	1	II	21/01/98	Mild skin redness	-	13/06/05	90
2	72	14/01/98	Total mast + tam	2.0	12	1	I	03/02/98	Mild skin redness	-	13/06/05	89
3	52	24/03/98	Partial mast + RT + tam	1.3	20	2	II	16/11/98	-	-	13/06/05	87
4	53	22/05/98	Partial mast + RT + tam	1.5	23	2	III	30/11/98	-	-	15/06/05	85
5	53	03/09/98	Total mast + tam	3.0	21	4	a	23/09/98	-	-	15/06/05	81
6	58	10/11/98	Total mast + tam	1.5	22	3	II	30/11/98	Mild skin redness	-	15/06/05	79
7	78	08/12/98	Bilateral total mast +tam	Right 1.2 Left 1.2	18 16	0 4	I I	28/12/98	-	-	17/06/05	78
8	62	27/01/99	Partial mast + RT + tam	1.0	8	1	II	16/02/99	Mild skin redness	-	17/06/05	77
9	61	01/04/99	Partial mast + RT + tam	2.0	18	1	I	26/04/99	-	-	17/06/05	74
10	58	21/04/99	Partial mast + RT + tam	2.0	17	3	II	07/05/99	-	-	20/06/05	74
11	53	13/07/99	Partial mast + RT + tam	2.3	29	1	a	19/08/99	Mild skin redness	-	20/06/05	71
12	59	16/09/99	Total mast + tam	1.4	19	1	I	26/06/00	-	-	20/06/05	69
13	59	10/11/99	Total mast + tam	0.7	10	1	a	22/11/99	-		22/06/05	67
14	63	09/02/00	Partial mast + RT + tam	1.2	13	1	II	01/03/00	-	-	22/06/05	64
15	55	10/02/00	Partial mast + RT + tam	2.5	23	3	II	25/02/00	-	-	24/06/05	64
16	65	29/06/00	Partial mast + RT + tam	0.8	17	1	II	17/07/00	Mild skin redness	-	24/06/05	60

^aThe histologic type was invasive lobular adenocarcinoma with no grading. mast, mastectomy; M-FP, oxidized mannan conjugated to MUC1 fusion protein; RT, radiotherapy; tam, tamoxifen.